AzTrials
AzTrials

ALL, ChildhoodNOURISH-ALLNCT06050850

Healthy Weight Intervention Families During ALL Treatment: NOURISH-ALL

A study testing NOURISH-ALL in people with ALL, Childhood and Behavior, Health, run by University of Kansas Medical Center at 2 sites in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record

Search all trials

Trial summary

The purpose of this study is to conduct a single arm pilot of the NOURISH-ALL (Nourishing Our Understanding of Role modeling to Improve Support and Health in Acute Lymphoblastic Leukemia) intervention focused on three components of participant engagement. Read more about this study

Who is it for?
Ages 2 to 12 years
Conditions the study is for
ALL, Childhood, Behavior, Health
What is being tested?
NOURISH-ALL
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
2 sitesUnited States
Study dates
1 Sep 2026to 1 Sep 2028
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children ages 2-12 years old and their primary caregiver ages 18-90
  • Child diagnosed with acute lymphoblastic leukemia (ALL)
  • Child completed induction phase of therapy and not yet in maintenance phase of therapy
  • Primary caregiver and child English language proficient
  • Primary caregiver able to provide permission for child to participate in research
  • Primary caregiver identifies as being involved with child's oncology care
  • Primary caregiver lives with child at least 50% of the time
  • Primary oncology provider confirms child is eligible to participate

Who cannot join

  • Primary oncology provider identifies safety concerns regarding the child's participation in the study.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Carolyn Bates, PhD contact

913-588-6323

cbates4@kumc.edu

Kelsey M Dean contact

(816) 652-0065

kdean@kumc.edu

United States2 sites
  • University of Kansas Medical Center

    Kansas City, Kansas, 66160

  • Children's Mercy Kansas City

    Kansas City, Missouri, 64118

    Keith August, MD, (816) 302-6801, kjaugust@cmh.edu

    Keith August, MD

Other trials in United States

About this study

Official title: A Healthy Weight Intervention for Family Stress During the Early Phases of ALL Treatment: NOURISH-ALL

The purpose of this study is to conduct a single arm pilot of the NOURISH-ALL (Nourishing Our Understanding of Role modeling to Improve Support and Health in Acute Lymphoblastic Leukemia) intervention focused on three components of participant engagement. This is a single arm intervention study that involves participation in a 6-session family intervention and three time points of multimethod data collection. The primary outcome is participant engagement, measured as recruitment, retention, and intended dose received.

This study will be conducted over 5 years in three phases:

  • Aim 1a: Adapting the NOURISH-ALL Intervention for Families of Youth with ALL (Year 1)
  • Aim 1b: Iteratively Refining the NOURISH-ALL Intervention (Year 2)
  • Aim 2: Pilot Single-Arm Trial of NOURISH-ALL Focused on Participant Engagement (Years 3-5)
Read the detailed description

The long-term goal of this work is to establish an efficacious family-based health promotion intervention that curbs excessive weight gain among youth with newly diagnosed acute lymphoblastic leukemia (ALL) by integrating support for family coping with stress during the early phases of treatment.

The objectives of the current study are to adapt an existing family-based health promotion intervention, NOURISH-T, to meet the needs of families of youth in the early phases of ALL treatment (NOURISH-ALL) and (2) assess three key components of engagement in preparation for a fully powered efficacy trial.

NOURISH-T is a 6-session family-based health promotion intervention that has demonstrated improved physical activity (PA), dietary intake, and weight among youth who are cancer survivors. Guided by the ORBIT Model of Behavioral Intervention Development, this study will modify NOURISH-T to fit the early ALL treatment context through a multi-stage adaptation and refinement process. Adaptations will incorporate family systems and cognitive behavioral intervention components to support healthy family coping with diagnosis and treatment stress. Additional, patient-centered adaptations will be informed by semi-structured family input around intervention content and delivery.

The central hypothesis is that this rigorous approach to adaptation will yield an intervention that is feasible, acceptable, and engaging for families of youth with ALL. By incorporating tailored strategies for health promotion during the early phases of ALL treatment, the proposed study seeks to shift clinical practice paradigms to prevent weight-related disparities in treatment outcomes.

Hypothesis:

The central hypothesis is that this rigorous approach to adaptation will yield an intervention that is feasible, acceptable, and engaging for families of youth with ALL.

Aims:

AIM 1: To (a) adapt the NOURISH-T intervention to target the early phases of ALL treatment (NOURISH-ALL) and (b) refine this ALL-tailored intervention for optimal feasibility and acceptability from the patient and family perspective. (Years 1-2) Defining the specific needs of families of youth with newly diagnosed ALL is essential to effectively adapting behavior change interventions to the early phases of ALL treatment. Refining interventions for optimal feasibility and acceptability from the family perspective is critical to successful intervention development.

Aim 1a: Intervention Adaptation. The purpose of Aim 1a is to adapt the NOURISH-T intervention to meet the specific needs of families during the early phases of ALL treatment. To achieve this goal, the study will initiate a three-step intervention adaptation process that includes (1) initial integration of cognitive behavioral therapy (CBT) and family systems frameworks, (2) formative assessment with families of youth with ALL, and (3) formative assessment with multidisciplinary experts.

Aim 1b. Refinement to Optimize Feasibility and Acceptability. The purpose of Aim 1b is to adaptively refine NOURISH-ALL through sequential testing with individual families during the early phases of ALL treatment, with the goal of optimizing feasibility and acceptability from the family perspective. In line with the ORBIT model, the study will utilize an adaptive approach, similar to the commonly known "PDSA cycle," to maximize responsivity to individual patient/family feedback. Participants will receive NOURISH-ALL and provide feedback throughout the intervention (i.e., after each session and upon intervention completion), which will be iteratively analyzed and incorporated to improve intervention delivery for the next family.

AIM 2: To conduct an external pilot single-arm trial of NOURISH-ALL focused on three components of engagement. (Years 3-5). Pilot testing key components of engagement is critical to optimizing design and methodology of fully powered efficacy trials. The purpose of Aim 2 is to pilot a single-arm trial of the finalized NOURISH-ALL intervention in a sample of families of youth in the early phases of ALL treatment to assess recruitment, retention, and dose received. Results will directly inform the design of the fully powered randomized control trial to test intervention efficacy (R01 application to be submitted in Year 4).

Being tested
NOURISH-ALL
Medical subject headings
Precursor Cell Lymphoblastic Leukemia-Lymphoma, Health Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • NOURISH-ALLBehavioural

    Our NOURISH-ALL intervention will build on this existing NOURISH-T family based behavioral intervention with families of cancer survivors. The intervention, NOURISH-ALL, will adapt these family-based health promotion strategies to the early ALL treatment context.

Study groups in NCT06050850
Study groupRoleWhat they receive
Aim 2: Pilot Single-Arm Trial of NOURISH-ALL Focused on Participant Engagement (Years 3-5)ExperimentalPilot testing key components of engagement is critical to optimizing design and methodology of fully powered efficacy trials. The purpose of Aim 2 is to pilot a single-arm trial of the finalized NOURISH-ALL intervention in a sample of families of youth in the early phases of ALL treatment to assess recruitment, retention, and dose received. Results will directly inform the design of the fully powered randomized control trial to test intervention efficacy (R01 application to be submitted in Year 4).
Receives: Behavioral: NOURISH-ALL

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Recruitment Rate

    Measured by # enrolled / # eligible

    Measured: Baseline (Week 0)

  2. Retention Rate

    Measured by # completed intervention / # enrolled

    Measured: Post-Intervention (Week 6), Follow-Up (Month 6)

  3. Intended dose received

    Measured by # sessions attended / # sessions offered

    Measured: Post-Intervention (Week 6), Follow-Up (Month 6)

Secondary outcomes (9)
  1. Child Body Mass Index (BMI)

    Measured by child height and weight

    Measured: Baseline (Week 0), Post-Intervention (Week 6), Follow-Up (Month 6)

  2. Child Physical Activity

    Measured by Actigraph wGT3x+ activity monitor

    Measured: Baseline (Week 0), Post-Intervention (Week 6), Follow-Up (Month 6)

  3. Child Sleep

    Measured by Actigraph wGT3x+ activity monitor

    Measured: Baseline (Week 0), Post-Intervention (Week 6), Follow-Up (Month 6)

  4. Child Dietary Intake

    Total calories, % calories from fat, and other nutrition variables will be measured by Automated Self-Administered 24-hour Dietary Assessment Tool (ASA24)

    Measured: Baseline (Week 0), Post-Intervention (Week 6), Follow-Up (Month 6)

  5. Family Stress Measures

    Measured by Psychosocial Assessment Tool v3.0 (PAT 3.0)

    Measured: Baseline (Week 0), Post-Intervention (Week 6), Follow-Up (Month 6)

  6. Family Distress

    Measured by Distress Thermometer (DT)

    Measured: Baseline (Week 0), Post-Intervention (Week 6), Follow-Up (Month 6)

  7. Body Composition - Bioelectrical Impedance Analysis

    Measured by InBody Scale bioelectrical impedance analysis

    Measured: Baseline (Week 0), Post-Intervention (Week 6), Follow-Up (Month 6)

  8. Body Composition

    Measured by dual energy x-ray absorptiometry (DXA) scan

    Measured: Baseline (Week 0), Post-Intervention (Week 6), Follow-Up (Month 6)

  9. Subcutaneous fat

    Skinfold thickness measurement

    Measured: Baseline (Week 0), Post-Intervention (Week 6), Follow-Up (Month 6)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Sep 2023
  2. Study start1 Sep 2026 (estimated)
  3. Primary completion1 Sep 2028 (estimated)
  4. Study completion1 Sep 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06050850
Sponsor's protocol ID
STUDY00002516
Other IDs
1K08CA279877-01A1
Acronym
NOURISH-ALL
Status last verified
Oct 2025
First submitted
8 Sep 2023
Last updated
8 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in